Pharmacovigilance signals of dupilumab among pediatric patients: A real‑world analysis based on the FAERS database
ABSTRACT Dupilumab is effective for the treatment of moderate‑to‑severe type 2 inflammatory diseases; however, its real‑world safety profile in pediatric patients remains to be further clarified. This retrospective pharmacovigilance study analyzed U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)...